Quotient (QTNT) Lowered to “Sell” at BidaskClub

Quotient (NASDAQ:QTNT) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, BidAskClub reports.

Other research analysts have also issued research reports about the stock. Jefferies Financial Group upped their price objective on shares of Quotient from $11.00 to $13.50 and gave the company a “buy” rating in a research note on Tuesday, March 5th. ValuEngine lowered shares of Quotient from a “strong-buy” rating to a “buy” rating in a research note on Friday, April 19th. Finally, Zacks Investment Research upgraded shares of Quotient from a “sell” rating to a “hold” rating in a research note on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. Quotient presently has an average rating of “Hold” and a consensus target price of $11.75.

Quotient stock opened at $9.26 on Tuesday. The company has a market capitalization of $544.96 million, a price-to-earnings ratio of -4.58 and a beta of 1.25. The company has a current ratio of 6.87, a quick ratio of 6.05 and a debt-to-equity ratio of 4.95. Quotient has a twelve month low of $4.54 and a twelve month high of $11.15.



In other news, President Edward Farrell sold 22,500 shares of the stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $8.67, for a total transaction of $195,075.00. Following the transaction, the president now owns 2,133 shares in the company, valued at approximately $18,493.11. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 17.40% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in QTNT. Granite Point Capital Management L.P. acquired a new position in shares of Quotient during the 4th quarter worth $1,346,000. Victory Capital Management Inc. purchased a new stake in Quotient in the 4th quarter worth about $1,224,000. Quantum Capital Management increased its holdings in Quotient by 42.3% in the 4th quarter. Quantum Capital Management now owns 385,558 shares of the company’s stock worth $2,360,000 after acquiring an additional 114,597 shares during the last quarter. Monashee Investment Management LLC purchased a new stake in Quotient in the 4th quarter worth about $1,530,000. Finally, Castleark Management LLC purchased a new stake in Quotient in the 4th quarter worth about $462,000. Institutional investors own 66.32% of the company’s stock.

Quotient Company Profile

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.

Recommended Story: Why is a lock-up period needed for an IPO?

Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.